← Back to home

Compounded Tirzepatide Vials Recalled Over Sterility Concerns, Not Lilly's Mounjaro or Zepbound

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

North Carolina compounder Apothecary Pharma is pulling 22 vials of its tirzepatide…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

3 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home